a total of 5 doses. Post-DBMT, the recipient was maintained on a tapering course of cyclosporine before complete withdrawal 28 days later. VCAs were assessed by serial clinical assessment and histopathology. Mixed chimerism in peripheral blood was monitored by flow cytometry and in vitro immunologic responses were assessed through mixed lymphocyte reaction (MLR) assays.
RESULTS:
Two recipients were euthanized within 2 weeks of DBMT due to neutropenic sepsis and posttransplant lymphoproliferative disorder but both VCAs remained viable up to experimental endpoint. M4515 (full MHC-mismatched recipient) has been off of all immunosuppression for 3 weeks without any evidence of rejection. M3815 (haplomatched) developed mixed chimerism transiently at 6 weeks after DBMT and corresponding MLR assays demonstrated decreased anti-donor responses; immunosuppression was then successfully withdrawn for a total of 5 weeks before rejection developed. Although the rejection episode could be reversed with steroid bolus and a tapering course of FK506, recurrence occurred after another 2 weeks off immunosuppression.
CONCLUSION:
As with the clinical experience with tocilizumab, vigilant monitoring is required following drug administration due to increased susceptibility to neutropenia and infections
1 . Tocilizumab appears to promote engraftment after DBMT to allow short-medium term immunosuppression-free VCA survival across haplomatched barriers in this NHP model. Continued follow-up is required to determine if similar results can be achieved across a full MHC mismatch. Further studies in our laboratory are focused on optimizing the current protocol to achieve stable engraftment and durable mixed chimerism for tolerance of VCA. ; when scaled up to DCD human livers, SNMP demonstrated sustained and enhanced viability of liver grafts. To expand the donor pool in VCA, we investigated the utility of SNMP on preservation time and resuscitation of ischemic limbs in a swine model.
METhOdS:
2 porcine forelimbs were procured and flushed with ice-cold UW on the back table through the cannulated axillary artery and veins. Warm ischemia was 45 mins and SCS was 2 hours. Before starting SNMP, the forelimbs were flushed with 1500 mL of cold Lactated Ringers. During SNMP (3 hours), the amputated forelimbs were perfused by a pressure-controlled system through the axillary artery. The perfusion solution consisted of William's E medium, which was enriched with dexamethasone, insulin and heparin. A venous outflow was prepared for sample collection. Hemodynamics of the limbs was monitored by evaluation of arterial flow and vascular resistance. Perfusion samples were collected at 30 min intervals for biochemical analysis. Lactate clearance was monitored as a marker of muscle injury. Muscle biopsies were collected at 60 min intervals for measurement of ATP production.
RESULTS:
Arterial outflow and vascular resistance remained stable throughout the perfusion, between 270 and 320 mL/min and 0.23 and 0.26 mmHg/mL/min, respectively. Despite the initial increase in lactate levels from 0.2 mmol/L to > 6 mmol/L, this value remained stable during the final hour of perfusion. The increase in ATP production reflects successful resuscitation of the forelimb, increasing from a baseline of 5500 before perfusion to 7500 nmol/g protein during SNMP.
CONCLUSIONS: SNMP has the potential to both actively preserve and enhance overall preservation of forelimbs in a swine model. It may provide the crucial enabling technology for tissue preservation, transport, and eventual transplantation of VCAs.
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MaTERIaLS aNd METhOdS:
Vascular networks were fabricated by sacrificing Pluronic F127 macrofibers in type I collagen with encapsulated human foreskin fibroblasts (HFF1) and human placental pericytes (HPPL) at a density of 1 x 10^6 cells/mL, respectively. Twenty-four hours following fiber sacrifice, 5 x 10^6 cells/mL of human aortic smooth muscle cells (HASMC) and 5 x 10^6 cells/mL of human umbilical vein endothelial cells (HUVEC) were seeded sequentially into the patent luminal space. Subsequently, 48 hours after fiber sacrifice, 1 x 10^6 cells/mL of human epidermal keratinocytes (HEK) were topically seeded onto scaffolds. Scaffolds were incubated at 1.5%, 5.0%, or 20.0% oxygen, underwent daily media changes, and were analyzed after 7 and 14 days in culture.
